XYL
54
2
UPS
51
-7
MTB
61
-3
TMO
54
2
BRK.B
38
-5
ETR
63
-3
AMT
45
2
V
70
-6
BIIB
40
-2
RL
80
-2
UA
48
-3
DE
62
-3
BBY
36
-5
MRK
37
4
A
41
-2
VRSN
58
-2
GIS
35
-2
PX
62
-4
FRT
41
-4
TGNA
53
-3
XYL
54
2
UPS
51
-7
MTB
61
-3
TMO
54
2
BRK.B
38
-5
ETR
63
-3
AMT
45
2
V
70
-6
BIIB
40
-2
RL
80
-2
UA
48
-3
DE
62
-3
BBY
36
-5
MRK
37
4
A
41
-2
VRSN
58
-2
GIS
35
-2
PX
62
-4
FRT
41
-4
TGNA
53
-3
Financhill
Back

Synopsys Vs. NovoCure Industry Stock Comparison

Buy
53

SNPS
Synopsys

Last Price:
588.60
Seasonality Move:
0.11%
Buy
77

NVCR
NovoCure

Last Price:
28.60
Seasonality Move:
2.04%
Buy
53
Synopsys (SNPS) is a Buy

Is Synopsys a Buy, Sell or Hold?

  • The current Synopsys [SNPS] share price is $570.19. The Score for SNPS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SNPS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SNPS Stock Price Chart

What is Synopsys's stock price today?

  • The Synopsys share price today is $570.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNPS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

SNPS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.25 Buy
Relative Strength Index (14 RSI): 61.05 Buy
Chaikin Money Flow: 676092 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (528.34 - 563.68) Buy
Bollinger Bands (100): (495.48 - 559.9) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 84.56 Buy
Chaikin Money Flow: -690353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 22.01) Buy
Bollinger Bands (100): (15.44 - 20.28) Buy

SNPS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 560.15 Buy
20-day SMA: 551.38 Buy
50-day SMA: 527.51 Buy
200-day SMA: 549.6 Buy
8-day EMA: 558.73 Buy
20-day EMA: 548.79 Buy
50-day EMA: 535.96 Buy
200-day EMA: 531.99 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Buy
20-day SMA: 18.85 Buy
50-day SMA: 17.12 Buy
200-day SMA: 17.34 Buy
8-day EMA: 23.1 Buy
20-day EMA: 19.92 Buy
50-day EMA: 18.23 Buy
200-day EMA: 19.07 Buy

Synopsys Earnings Growth & SNPS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.05 per share, and an increase next year of $1.75 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Synopsys Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):